Kaiser Permanente Washington Health Research Institute recently received word of 3 new awards.
A 4-year, $334,563 grant from the Food and Drug Administration (FDA). Major goals: The main aim of this study is to validate the FDA’s COVID-19 disease severity definitions from the COVID natural history protocol using medical record review. The Kaiser Permanente Washington Health Research Institute lead investigator is Gaia Pocobelli.
A 3-year, $1,938,672 grant from the National Institute of Mental Health. Major goals: For teens 13 to 17 years old with preventive visits, our aims are to:
The Kaiser Permanente Washington Health Research Institute lead investigator is Gwen Lapham.
A 3-year, $3,391,349 grant from the National Institute of Mental Health. Major goals: The major goals are to use data from 4 health systems to identify and address racial, ethnic, and other biases in measures of care quality for depression and anxiety. The Kaiser Permanente Washington Health Research Institute lead investigator is Gregory Simon.
Kaiser Permanente Washington Health Research Institute recently received word of 4 new awards.
A 1-year, $ 683,198 grant from the National Institute of Mental Health. Major goals: To conduct an implementation study across 30 primary care clinics on the effectiveness of teen suicide prevention with confidential care. The Kaiser Permanente Washington Health Research Institute lead investigator is Gwen Lapham.
A 1-year, $50,000 grant from CommonSpirit Health. Major goals: The major goal of this project is to support 6 CommonSpirit health sites with a community health worker pilot evaluation design, including creating a logic model, evaluation plan, and metrics for success, and providing general technical assistance. The Kaiser Permanente Washington Health Research Institute lead investigator is Maggie Jones.
A 1-year, $27,677 grant from the National Heart, Lung, and Blood Institute. Major goals: To use community collaborations with faith-based centers and electronic communications to improve hypertension control in Nigeria. The Kaiser Permanente Washington Health Research Institute lead investigator is Beverly Green.
A 3-year, $2,392,868 grant from the Department of Health and Human Services. Major goals: We will use longitudinal records data from 4 health systems to test specific hypotheses regarding consistency of response to antidepressant medications and derive new rules to personalize antidepressant treatment. The Kaiser Permanente Washington Health Research Institute lead investigator is Gregory Simon.
Kaiser Permanente Washington Health Research Institute recently received word of a new award.
A 5-year, $358,491 grant from the National Institute on Alcohol Abuse and Alcoholism. Major goals: The overall goal of the project is to develop, validate, and apply a computer simulation model to inform policymakers, physicians, and patients of the lifetime benefit of treatments for alcohol use disorder in U.S. adults. The Kaiser Permanente Washington Health Research Institute lead investigator is Katharine Bradley.
Kaiser Permanente Washington Health Research Institute recently received word of 3 new awards.
A 1-year, $34,406 grant from Cedars-Sinai. Major goals: The major goal of this project is to provide feasibility data on digital mammogram capture for an upcoming grant submission. The Kaiser Permanente Washington Health Research Institute lead investigator is Erin Bowles.
A 2-year, $91,054 grant from the National Institute of Mental Health. Major goals: The major goal of this project is to understand the perspectives of Washington State Department of Corrections (DOC) stakeholders on opioid use disorder (OUD) identification in patients with and without HIV and to work with DOC leadership to integrate evidence-based OUD assessment into the DOC’s HIV treatment and prevention programs. The Kaiser Permanente Washington Health Research Institute lead investigator is Leah Hamilton.
A 4-year, $36,633 grant from the National Institute of Diabetes and Digestive and Kidney Diseases. Major goals: The major goals of this project are to build upon the previously developed CNN Hip Accelerometer Posture (CHAP) model — a novel deep learning convolution neural network (CNN) bidirectional long short-term memory (BiLSTM) model. CHAP classifies posture (sitting versus not sitting) using hip-worn accelerometers and predicted postural transitions with high accuracy. Here we aim to test CHAP’s performance in diverse cohorts, develop transfer learning approaches for CHAP to minimize the need for retraining, expand CHAP data intake capacity into both older and wrist-worn accelerometer technology, and apply CHAP in larger cohorts for epidemiological evidence. The Kaiser Permanente Washington Health Research Institute lead investigator is Mikael Anne Greenwood-Hickman.
Kaiser Permanente Washington Health Research Institute recently received word of 6 new awards.
A 1-year, $40,000 grant from the Kaiser Permanente Program Office. Major goals: The major goal of the Benefits Data Trust (BDT) evaluation project is to study the value, utilization, and impact of BDT for Kaiser Permanente’s Maryland members’ social health needs. The Center for Community Health and Evaluation will use a mixed-methods approach and synthesize the findings into a series of recommendations related to outbound national campaigns. The Kaiser Permanente Washington Health Research Institute lead investigator is Melissa Trapp Petty.
A 5-year, $800,165 grant from the National Cancer Institute. Major goals: The proposed study will develop and validate breast cancer risk prediction models for women with a high-risk benign breast diagnosis. The Kaiser Permanente Washington Health Research Institute lead investigator is Ellen O'Meara.
A 1-year, $30,456 grant from the National Cancer Institute. Major goals: The major goals of this project are to conduct oncology clinical trials. The Kaiser Permanente Washington Health Research Institute lead investigator is Eric Chen.
A 1-year, $70,238 grant from the Kaiser Permanente Program Office. Major goals: The major goal of this project is to explore biobank participant and clinical stakeholder perspectives on equitably returning genetic results to biobank participants. The Kaiser Permanente Washington Health Research Institute lead investigator is Nora Henrikson.
A 1-year, $15,000 grant from the KPWHRI Small Grants Program. Major goals: The major goal of this project is to complete preparation-phase activities to inform the optimization of a peer support intervention for youth mental health. Key activities include (1) identifying critical targets of peer support interventions for youth mental health and (2) synthesizing the current literature to identify candidate peer support intervention components that can address those critical targets. The Kaiser Permanente Washington Health Research Institute lead investigator is Rosemary Meza.
A 1-year, $14,981 grant from the KPWHRI Small Grants Program. Major goals: The major goal of this project is to create and validate a natural language processing pipeline that differentiates initial emergency department (ED) visits for self-harm from follow-up ED visits for self-harm. The Kaiser Permanente Washington Health Research Institute lead investigator is David Cronkite.
Kaiser Permanente Washington Health Research Institute recently received word of 4 new awards.
A 4-year, $2,661,200 grant from the National Institute of Diabetes and Digestive and Kidney Diseases. Major goals: The major goals of this project are to compare the effectiveness and safety of metabolic/bariatric surgery and GLP-1 and SGLT-2 medications for patients with obesity and type 2 diabetes. The Kaiser Permanente Washington Health Research Institute lead investigator is David Arterburn.
A 1-year, $80,621 grant from the National Cancer Institute. Major goals: The major goal of this project is to develop and validate a comprehensive breast cancer risk assessment tool. The tool will predict risk overall and by subtype across major ethnic groups in the United States. We will also prospectively validate the model in different clinical settings. The Kaiser Permanente Washington Health Research Institute lead investigator is Ellen O'Meara.
A 1-year, $374,498 grant from the Food and Drug Administration. Major goals: The major goals are to assess the feasibility of developing computable phenotypes for 20 to 30 health outcomes that have been challenging to study using administrative claims data in the Active Risk Identification and Analysis (ARIA) system, employing more advanced methods such as natural language processing or incorporating richer data from electronic health records (EHRs). The project will also contribute to a protocol and analyses using real-world linked claims and EHR data to study drug-disease associations that were deemed too challenging to study using claims data alone. The Kaiser Permanente Washington Health Research Institute lead investigator is Sascha Dublin.
A 1-year, $393,087 grant from the Food and Drug Administration. Major goals: The major goal of this project is to develop an empirical case study for the Sentinel Innovation Center. We will identify an appropriate ARIA sufficient case study and apply subset calibration tools for correcting claims-only analyses for potential unmeasured confounding using data gathered from electronic health records. The Kaiser Permanente Washington Health Research Institute lead investigator is Susan Shortreed.
Kaiser Permanente Washington Health Research Institute recently received word of 3 new awards.
A 2-year, $234,427 grant from California Health Care Foundation. Major goals: The major goals of this project are to conduct an evaluation of the EQuIP-LA program to help all partners better understand the successes and limitations of the program and assess and document the experiences of participants. This includes assessing program impact and participants’ progress, elevating facilitators and barriers, and evaluating perceptions and utilization of program supports. The Kaiser Permanente Washington Health Research Institute lead investigator is Lisa Schafer.
A 5-year, $402,929 grant from the National Heart, Lung, and Blood Institute. Major goals: The major goals of this project are (1) to address critical questions on the long-term efficacy and safety of anti-obesity medications approved by the Food and Drug Administration and (2) to assess hard clinical outcomes of these drugs (for example, incident diabetes, hypertension, cardiovascular events) and their impact on health care use and costs. The Kaiser Permanente Washington Health Research Institute lead investigator is David Arterburn.
A 1-year, $58,832 grant from the National Institute of Child Health and Human Development. Major goals: The major goals of this project are to characterize differences in the incidence and treatment of urinary tract infection in pregnancy by race and ethnicity, including differences in choice of antibiotic and concordance of treatment with clinical guidelines; and to support Sandra McAteer, a master’s student in epidemiology at the University of Washington, in conducting research and gaining skills and experience needed for a successful career in maternal and child health interventions. The Kaiser Permanente Washington Health Research Institute lead investigator is Sascha Dublin.
Kaiser Permanente Washington Health Research Institute recently received word of 5 new awards.
A 1-year, $25,000 grant from the Helmsley Charitable Trust. Major goals: To provide consultation on evaluation design for up to 4 pilot projects funded as part of Acumen America's Medicaid Innovation Collaborative (MIC) Tech Enabled Social Determinants of Health Pilot Program. The Kaiser Permanente Washington Health Research Institute lead investigator is Maggie Jones.
A 2-year, $239,769 grant from the California Health Care Foundation. Major goals: To understand the Hazel Health telemental health implementation in schools. The Kaiser Permanente Washington Health Research Institute lead investigator is Natasha Arora.
A 1-year, $50,000 grant from Free From Market. Major goals: To evaluate a pilot program to provide access to Free From Market (a virtual food pantry) to high-risk pregnant people in Kansas who are experiencing food insecurity. The Kaiser Permanente Washington Health Research Institute lead investigator is Elena Kuo.
A 1-year, $200,000 grant from the Food and Drug Administration. Major goals: To derive health care risk factors such as smoking status and history of suicide attempt from clinical free text using natural language processing. The newly generated features will populate a new table in the FDA Sentinel common data model. The Kaiser Permanente Washington Health Research Institute lead investigator is Robert Penfold.
A 5-year, $4,999,458 grant from the Agency for Healthcare Research and Quality. Major goals: The major goal of the Washington Learning Health System (LHS) E-STAR Center is to train a diverse set of independent scientists with a solid foundation in LHS research who can change the paradigm of primary care research through research that rapidly develops and implements evidence while simultaneously building LHS capacity in safety net primary care settings. The Kaiser Permanente Washington Health Research Institute lead investigator is Paula Lozano.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.